US gives AstraZenena $1 billion for Oxford vaccine

spike

AstraZeneca, South San Francisco, California, April 11, 2020.

Smith Collection/Gado/Getty Images

AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority (BARDA) to develop a coronavirus vaccine from the University of Oxford. 

The British-Swedish drugmaker has agreed to initially supply at least 400 million doses of the vaccine and secured total manufacturing capacity to produce 1 billion doses, with first deliveries in September. 

AstraZeneca’s development program of the vaccine includes a phase three clinical trial with 30,000 participants and a pediatric trial.

Pascal Soriot, CEO of AstraZeneca, said the drugmaker would do

Read More